Recent advancements in science have prompted a new exploration of the concept of aging. Researchers claim that two commonly used medications-Rapamycin and Metformin, which are typically employed in the treatment of cancer and diabetes-may together enhance human longevity when administered in appropriate doses. This groundbreaking study was initiated by a team at the University of East Anglia’s School of Biological Sciences. They believe that combining Rapamycin, often used during cancer treatment and organ transplantation, with Metformin, primarily prescribed for type 2 diabetes, could halt cellular division and degradation processes, contributing to increased lifespan.
Experts assert that these medications could reduce the accumulation of calories in the body without necessitating prolonged fasting or strict dietary restrictions. Moreover, they may help preserve essential cellular components, particularly the telomeres-segments of chromosomes that play a crucial role in cellular division. This section of the chromosomes determines how many times a cell can divide. Scientists have noted that cellular efficiency tends to decrease after age 30, with heart, liver, and kidney functionality dropping by 20% by age 50. Beyond age 80, this decline can exceed 50%. However, the new application of these drugs may slow down this degradation, aiding organs in maintaining functionality for a longer period.
Currently, these medications are being tested on animals, and researchers emphasize the necessity for further studies before results can be effectively applied to humans. They predict that it might take additional time before findings are published. With this potential scientific breakthrough, there is hope that the understanding of aging may soon become a relic of the past. If we can prevent cellular degradation and maintain the creation of new cells, human life may become healthier and significantly longer.
Original Source: https://assam.nenow.in/rapamycin-metformin-anti-aging-research-2025/
Category: জীৱনশৈলী,শীর্ষ সংবাদ
Tags:
Publish Date: 2025-07-22 06:32:00
